Cargando…
Attenuation of the Infiltration of Angiotensin II Expressing CD3(+) T-Cells and the Modulation of Nerve Growth Factor in Lumbar Dorsal Root Ganglia – A Possible Mechanism Underpinning Analgesia Produced by EMA300, An Angiotensin II Type 2 (AT(2)) Receptor Antagonist
Recent preclinical and proof-of-concept clinical studies have shown promising analgesic efficacy of selective small molecule angiotensin II type 2 (AT(2)) receptor antagonists in the alleviation of peripheral neuropathic pain. However, their cellular and molecular mechanism of action requires furthe...
Autores principales: | Khan, Nemat, Muralidharan, Arjun, Smith, Maree T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696600/ https://www.ncbi.nlm.nih.gov/pubmed/29200998 http://dx.doi.org/10.3389/fnmol.2017.00389 |
Ejemplares similares
-
Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT(2)R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies
por: Anand, Uma, et al.
Publicado: (2015) -
Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011) -
Spectrofluorimetric method for determination of some angiotensin II receptor antagonists
por: El-Shaboury, Salwa R., et al.
Publicado: (2012) -
Angiotensin II receptor antagonists a potential therapy for SARS
Publicado: (2013) -
Propofol inhibits expression of angiotensin II receptor type 2 in dorsal root ganglion neurons
por: Pan, Bingbing, et al.
Publicado: (2017)